Quick Answer
IOVANCE BIOTHERAPEUTICS, INC. reported Net Income of -$390.98 million for fiscal year 2025.
IOVANCE BIOTHERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$390.98M | -5.1% |
| 2024 | -$372.18M | +16.2% |
| 2023 | -$444.04M | -12.2% |
| 2022 | -$395.89M | -15.7% |
| 2021 | -$342.25M | -31.8% |
| 2020 | -$259.58M | -31.4% |
| 2019 | -$197.56M | -59.9% |
| 2018 | -$123.58M | -34.2% |
| 2017 | -$92.06M | -74.1% |
| 2016 | -$52.89M | -91.2% |
| 2015 | -$27.66M | -129.8% |
| 2014 | -$12.04M | +52.6% |
| 2013 | -$25.38M | -667.4% |
| 2012 | -$3.31M | +87.1% |
| 2011 | -$25.69M | -1497.9% |
| 2010 | -$1.61M | -10095.2% |
| 2009 | -$15.8K | +73.1% |
| 2008 | -$58.7K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$91.25M | -9.2% | +18.3% |
| June 30, 2025 | -$111.66M | -15.0% | +3.9% |
| March 31, 2025 | -$116.16M | -2.8% | -39.0% |
| September 30, 2024 | -$83.54M | +26.6% | +14.0% |
| June 30, 2024 | -$97.10M | +8.8% | +14.1% |
| March 31, 2024 | -$112.98M | -5.2% | +0.7% |
| September 30, 2023 | -$113.76M | -14.2% | -6.8% |
| June 30, 2023 | -$106.53M | -7.2% | +0.8% |
- IOVANCE BIOTHERAPEUTICS, INC. showed a decrease of -5.1% in Net Income compared to the prior fiscal year.
- Over the 2008–2025 period, IOVANCE BIOTHERAPEUTICS, INC.’s net income has declined by 665779.8% (from -$58.7 thousand to -$390.98 million).
- The most recent figure is from IOVANCE BIOTHERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: